Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNAI2 GNAO1 GNAT1 GNAZ	1.52e-05	25	122	4	GO:0031683
GeneOntologyMolecularFunction	arachidonate 12(S)-lipoxygenase activity	ALOX12B ALOX15	2.20e-04	4	122	2	GO:0004052
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor binding	GNAO1 GNAZ	3.66e-04	5	122	2	GO:0031821
GeneOntologyMolecularFunction	N-formyl peptide receptor activity	GPR32 GPR32P1	3.66e-04	5	122	2	GO:0004982
GeneOntologyCellularComponent	heterotrimeric G-protein complex	GNAI2 GNAO1 GNAT1 GNAZ	4.87e-05	35	121	4	GO:0005834
GeneOntologyCellularComponent	GTPase complex	GNAI2 GNAO1 GNAT1 GNAZ	9.17e-05	41	121	4	GO:1905360
GeneOntologyCellularComponent	cytoplasmic side of plasma membrane	DSG1 RYR3 GNAI2 GNAO1 GNAT1 GNAZ ALOX15	1.03e-04	185	121	7	GO:0009898
GeneOntologyCellularComponent	extrinsic component of cytoplasmic side of plasma membrane	GNAI2 GNAO1 GNAT1 GNAZ	3.11e-04	56	121	4	GO:0031234
GeneOntologyCellularComponent	cytoplasmic side of membrane	DSG1 RYR3 GNAI2 GNAO1 GNAT1 GNAZ ALOX15	3.89e-04	230	121	7	GO:0098562
Domain	Gprotein_alpha_I	GNAI2 GNAO1 GNAT1 GNAZ	1.08e-07	8	119	4	IPR001408
Domain	GproteinA_insert	GNAI2 GNAO1 GNAT1 GNAZ	2.69e-06	16	119	4	IPR011025
Domain	-	GNAI2 GNAO1 GNAT1 GNAZ	2.69e-06	16	119	4	1.10.400.10
Domain	G-alpha	GNAI2 GNAO1 GNAT1 GNAZ	2.69e-06	16	119	4	PF00503
Domain	G_alpha	GNAI2 GNAO1 GNAT1 GNAZ	2.69e-06	16	119	4	SM00275
Domain	Gprotein_alpha_su	GNAI2 GNAO1 GNAT1 GNAZ	3.50e-06	17	119	4	IPR001019
Domain	Protein_Kinase_C_mu-related	PRKD2 PRKD1	1.20e-04	3	119	2	IPR015727
Domain	MAP1	MAP1A MAP1B	1.20e-04	3	119	2	IPR026074
Domain	PSI	PLXNA3 ITGB8 SEMA6D PLXNC1	1.75e-04	44	119	4	IPR016201
Domain	PSI	PLXNA3 ITGB8 SEMA6D PLXNC1	2.08e-04	46	119	4	SM00423
Domain	Desmoglein	DSG1 DSG4	2.40e-04	4	119	2	IPR009123
Domain	Hox9_activation_N	HOXB9 HOXD9	2.40e-04	4	119	2	IPR006711
Domain	HXA9/HXB9/HXC9	HOXB9 HOXD9	2.40e-04	4	119	2	IPR017112
Domain	Hox9_act	HOXB9 HOXD9	2.40e-04	4	119	2	PF04617
Domain	3'-5'_exonuclease_dom	EXD3 EXD2	3.98e-04	5	119	2	IPR002562
Domain	35EXOc	EXD3 EXD2	3.98e-04	5	119	2	SM00474
Domain	DNA_pol_A_exo1	EXD3 EXD2	3.98e-04	5	119	2	PF01612
Domain	Spectrin	KALRN ACTN2 ACTN3	4.07e-04	23	119	3	PF00435
Domain	ACTININ_2	ACTN2 ACTN3 CLMN	4.07e-04	23	119	3	PS00020
Domain	ACTININ_1	ACTN2 ACTN3 CLMN	4.07e-04	23	119	3	PS00019
Domain	Actinin_actin-bd_CS	ACTN2 ACTN3 CLMN	4.07e-04	23	119	3	IPR001589
Domain	LipOase_mml	ALOX12B ALOX15	5.94e-04	6	119	2	IPR001885
Domain	LIPOXYGENASE_1	ALOX12B ALOX15	5.94e-04	6	119	2	PS00711
Domain	LipOase_C	ALOX12B ALOX15	5.94e-04	6	119	2	IPR013819
Domain	LIPOXYGENASE_2	ALOX12B ALOX15	5.94e-04	6	119	2	PS00081
Domain	LipOase_Fe_BS	ALOX12B ALOX15	5.94e-04	6	119	2	IPR020833
Domain	LipOase_CS	ALOX12B ALOX15	5.94e-04	6	119	2	IPR020834
Domain	EFhand_Ca_insen	ACTN2 ACTN3	5.94e-04	6	119	2	PF08726
Domain	EF-hand_Ca_insen	ACTN2 ACTN3	5.94e-04	6	119	2	IPR014837
Domain	Lipoxygenase	ALOX12B ALOX15	5.94e-04	6	119	2	PF00305
Domain	LIPOXYGENASE_3	ALOX12B ALOX15	5.94e-04	6	119	2	PS51393
Domain	LipOase	ALOX12B ALOX15	5.94e-04	6	119	2	IPR000907
Domain	Spectrin_repeat	KALRN ACTN2 ACTN3	8.17e-04	29	119	3	IPR002017
Domain	Desmosomal_cadherin	DSG1 DSG4	8.28e-04	7	119	2	IPR009122
Domain	Semap_dom	PLXNA3 SEMA6D PLXNC1	9.95e-04	31	119	3	IPR001627
Domain	SEMA	PLXNA3 SEMA6D PLXNC1	9.95e-04	31	119	3	PS51004
Domain	Sema	PLXNA3 SEMA6D PLXNC1	9.95e-04	31	119	3	SM00630
Domain	Sema	PLXNA3 SEMA6D PLXNC1	9.95e-04	31	119	3	PF01403
Domain	Plexin_repeat	PLXNA3 SEMA6D PLXNC1	1.09e-03	32	119	3	IPR002165
Domain	SPEC	KALRN ACTN2 ACTN3	1.09e-03	32	119	3	SM00150
Domain	PSI	PLXNA3 SEMA6D PLXNC1	1.09e-03	32	119	3	PF01437
Domain	Spectrin/alpha-actinin	KALRN ACTN2 ACTN3	1.09e-03	32	119	3	IPR018159
Domain	DHC_N1	DYNC2H1 DNAH5	1.10e-03	8	119	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH5	1.10e-03	8	119	2	IPR013594
Domain	Plexin_cytopl	PLXNA3 PLXNC1	1.41e-03	9	119	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNC1	1.41e-03	9	119	2	IPR013548
Domain	Plexin	PLXNA3 PLXNC1	1.41e-03	9	119	2	IPR031148
Domain	-	REV3L EXD3 EXD2	3.33e-03	47	119	3	3.30.420.10
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH5	3.48e-03	14	119	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH5	3.48e-03	14	119	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH5	3.48e-03	14	119	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH5	3.48e-03	14	119	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH5	3.48e-03	14	119	2	IPR011704
Domain	MT	DYNC2H1 DNAH5	3.48e-03	14	119	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH5	3.48e-03	14	119	2	PF12780
Domain	AAA_5	DYNC2H1 DNAH5	3.48e-03	14	119	2	PF07728
Domain	PH	PRKD2 KALRN KIF1B AFAP1 PRKD1 ADAP2	3.50e-03	229	119	6	PF00169
Domain	DHC_fam	DYNC2H1 DNAH5	4.00e-03	15	119	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH5	4.00e-03	15	119	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH5	4.00e-03	15	119	2	IPR004273
Domain	LH2	ALOX12B ALOX15	5.76e-03	18	119	2	SM00308
Pathway	WP_PURINERGIC_SIGNALING	GNAI2 GNAO1 GNAT1 GNAZ	4.62e-05	33	86	4	M39855
Pathway	PID_S1P_S1P4_PATHWAY	GNAI2 GNAO1 GNAZ	7.60e-05	14	86	3	M64
Pathway	PID_HEDGEHOG_GLI_PATHWAY	CREBBP GNAI2 GNAO1 GNAZ	2.05e-04	48	86	4	M219
Pathway	PID_S1P_S1P1_PATHWAY	GNAI2 GNAO1 GNAZ	2.69e-04	21	86	3	M103
Pathway	PID_S1P_META_PATHWAY	GNAI2 GNAO1 GNAZ	2.69e-04	21	86	3	M155
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR3 PRKD1 GNAI2 GNAO1 GNAZ ATP1B1	2.75e-04	147	86	6	MM15854
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR3 PRKD1 GNAI2 GNAO1 GNAZ ATP1B1	3.18e-04	151	86	6	M39329
Pathway	PID_S1P_S1P2_PATHWAY	GNAI2 GNAO1 GNAZ	4.04e-04	24	86	3	M268
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 FNBP1 DNAJC13 CAND1 EPHA6 MAP1B VPS13C CCDC32 KIF1B HECTD4 CHD2 TTYH3 UBN2 F7 CREBBP EXD3 NETO1 CLMN SETBP1 TTC21B COBL PRKD1 GNAZ HPS5 POLK EPB41L1 RIC1 CLBA1	3.55e-13	1489	124	28	28611215
Pubmed	The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.	GNAI2 GNAO1 GNAT1 GNAZ	3.18e-08	10	124	4	8521505
Pubmed	Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein.	GNAI2 GNAO1 GNAT1 GNAZ	1.07e-07	13	124	4	8208289
Pubmed	Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins.	GNAI2 GNAO1 GNAT1 GNAZ	1.07e-07	13	124	4	16892066
Pubmed	Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1).	GNAI2 GNAO1 GNAT1 GNAZ	2.04e-07	15	124	4	11118617
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS1 KIR2DS3 KIR2DS4	4.40e-07	5	124	3	19410616
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 CASP8AP2 CAND1 KIF26A VPS13C RNF44 DLGAP5 HECTD4 AFAP1 NUP155 SETBP1 HPS5	4.61e-07	529	124	12	14621295
Pubmed	The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein.	GNAI2 GNAO1 GNAZ	8.78e-07	6	124	3	9647645
Pubmed	GAIP is membrane-anchored by palmitoylation and interacts with the activated (GTP-bound) form of G alpha i subunits.	GNAI2 GNAO1 GNAZ	1.53e-06	7	124	3	8986788
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS1 KIR2DS3 KIR2DS4	2.45e-06	8	124	3	18681957
Pubmed	G protein gene expression during mouse oocyte growth and maturation, and preimplantation embryo development.	GNAI2 GNAO1 GNAT1 GNAZ	2.95e-06	28	124	4	8858601
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FNBP1 DYNC2H1 UBR4 DLGAP5 CHD2 REV3L CREBBP LIG3 EXD3 IRAK3 HFM1 DSG4	3.22e-06	638	124	12	31182584
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS1 KIR2DS3 KIR2DS4	3.66e-06	9	124	3	18340360
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DS1 KIR2DS3 KIR2DS4	5.21e-06	10	124	3	21206914
Pubmed	Developmental expression of heterotrimeric G-proteins in the murine cerebellar cortex.	GNAI2 GNAO1 GNAZ	7.15e-06	11	124	3	11685543
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS1 KIR2DS3 KIR2DS4	7.15e-06	11	124	3	19664392
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	RALGAPA1 CAND1 MAP1A KALRN GNAO1 GNAZ ATP1B1 EPB41L1	8.06e-06	281	124	8	28706196
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS1 KIR2DS3 KIR2DS4	9.51e-06	12	124	3	20371502
Pubmed	Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein.	RAET1E GNAI2 ATP1B1	9.51e-06	12	124	3	8070621
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS1 KIR2DS3 KIR2DS4	9.51e-06	12	124	3	19181658
Pubmed	Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse.	GNAI2 GNAO1 GNAZ	9.51e-06	12	124	3	2508088
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS1 KIR2DS3 KIR2DS4	9.51e-06	12	124	3	20137308
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS1 KIR2DS3 KIR2DS4	9.51e-06	12	124	3	19936734
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS1 KIR2DS3 KIR2DS4	1.23e-05	13	124	3	18687225
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS1 KIR2DS3 KIR2DS4	1.23e-05	13	124	3	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS1 KIR2DS3 KIR2DS4	1.23e-05	13	124	3	19120281
Pubmed	The α-subunit of the trimeric GTPase Go2 regulates axonal growth.	GNAI2 GNAO1	1.26e-05	2	124	2	23373526
Pubmed	Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.	MAP1A MAP1B	1.26e-05	2	124	2	7806212
Pubmed	Alternative splicing produces transcripts encoding two forms of the alpha subunit of GTP-binding protein Go.	GNAO1 GNAT1	1.26e-05	2	124	2	1697681
Pubmed	Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.	MAP1A MAP1B	1.26e-05	2	124	2	11002287
Pubmed	Human skeletal muscle-specific alpha-actinin-2 and -3 isoforms form homodimers and heterodimers in vitro and in vivo.	ACTN2 ACTN3	1.26e-05	2	124	2	9675099
Pubmed	Both the establishment and maintenance of neuronal polarity require the activity of protein kinase D in the Golgi apparatus.	PRKD2 PRKD1	1.26e-05	2	124	2	18753385
Pubmed	Primary structure of the alpha-subunit of transducin and its relationship to ras proteins.	GNAT1 GNAZ	1.26e-05	2	124	2	3923359
Pubmed	Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes.	ACTN2 ACTN3	1.26e-05	2	124	2	19150855
Pubmed	Functional redundancy of protein kinase D1 and protein kinase D2 in neuronal polarity.	PRKD2 PRKD1	1.26e-05	2	124	2	25639845
Pubmed	The role of PKD in cell polarity, biosynthetic pathways, and organelle/F-actin distribution.	PRKD2 PRKD1	1.26e-05	2	124	2	24492625
Pubmed	Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells.	PRKD2 PRKD1	1.26e-05	2	124	2	20819079
Pubmed	Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system.	PRKD2 PRKD1	1.26e-05	2	124	2	22217708
Pubmed	Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.	PRKD2 PRKD1	1.26e-05	2	124	2	30843621
Pubmed	α-Actinin-2 deficiency results in sarcomeric defects in zebrafish that cannot be rescued by α-actinin-3 revealing functional differences between sarcomeric isoforms.	ACTN2 ACTN3	1.26e-05	2	124	2	22253474
Pubmed	alpha-actinin-3 and performance.	ACTN2 ACTN3	1.26e-05	2	124	2	19696509
Pubmed	Heterotypic complex formation between subunits of microtubule-associated proteins 1A and 1B is due to interaction of conserved domains.	MAP1A MAP1B	1.26e-05	2	124	2	16996626
Pubmed	Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases.	PRKD2 PRKD1	1.26e-05	2	124	2	24336522
Pubmed	Neuronal abnormalities in microtubule-associated protein 1B mutant mice.	MAP1A MAP1B	1.26e-05	2	124	2	8577753
Pubmed	Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain.	MAP1A MAP1B	1.26e-05	2	124	2	2355215
Pubmed	Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects.	GNAI2 GNAO1	1.26e-05	2	124	2	16456099
Pubmed	Differential regulation of Actn2 and Actn3 expression during unfolded protein response in C2C12 myotubes.	ACTN2 ACTN3	1.26e-05	2	124	2	32451822
Pubmed	Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11.	ACTN2 ACTN3	1.26e-05	2	124	2	1339456
Pubmed	The mouse and rat MAP1B genes: genomic organization and alternative transcription.	MAP1A MAP1B	1.26e-05	2	124	2	9615228
Pubmed	Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene.	MAP1A MAP1B	1.26e-05	2	124	2	9199175
Pubmed	Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.	DSG1 KLK5	1.26e-05	2	124	2	21163944
Pubmed	Whole exome sequencing in recurrent early pregnancy loss.	DYNC2H1 ALOX15	1.26e-05	2	124	2	26826164
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS1 KIR2DS3 KIR2DS4	1.56e-05	14	124	3	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS1 KIR2DS3 KIR2DS4	1.56e-05	14	124	3	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS1 KIR2DS3 KIR2DS4	1.56e-05	14	124	3	15896204
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS1 KIR2DS3 KIR2DS4	1.56e-05	14	124	3	19489269
Pubmed	A role for the EphA family in the topographic targeting of vomeronasal axons.	EPHA6 GNAI2 GNAO1	1.56e-05	14	124	3	11222144
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	19926642
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	19850842
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	19493232
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	20356536
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS1 KIR2DS3 KIR2DS4	1.95e-05	15	124	3	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	18668235
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	19309280
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	20331834
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	16403292
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS1 KIR2DS3 KIR2DS4	2.39e-05	16	124	3	20210919
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DNAJC13 CAND1 MAP1B DSG1 UBR4 DLGAP5 MAP3K20 CHD2 CREBBP LIG3 RPL7L1 NUP155 MCM3AP GNAI2 CDC5L ALOX12B	2.63e-05	1353	124	16	29467282
Pubmed	Evolution of the mammalian G protein alpha subunit multigene family.	GNAI2 GNAO1 GNAT1 GNAZ	2.88e-05	49	124	4	1302014
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19968064
Pubmed	Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women.	CD93 IRAK3 ALOX12B	2.90e-05	17	124	3	19372141
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19169284
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS1 KIR2DS3 KIR2DS4	2.90e-05	17	124	3	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	20519398
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	19046302
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	19846535
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS1 KIR2DS3 KIR2DS4	3.47e-05	18	124	3	20580654
Pubmed	Aloxe3 knockout mice reveal a function of epidermal lipoxygenase-3 as hepoxilin synthase and its pivotal role in barrier formation.	ALOX12B ALOX15	3.77e-05	3	124	2	22832496
Cytoband	19q13.4	ZNF132 KIR2DS1 KIR2DS3 KIR2DS4	6.51e-05	79	124	4	19q13.4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS1 KIR2DS3 KIR2DS4	6.02e-05	18	78	3	620
GeneFamily	Actinins	ACTN2 ACTN3	1.10e-04	4	78	2	1112
GeneFamily	Arachidonate lipoxygenases	ALOX12B ALOX15	2.73e-04	6	78	2	407
GeneFamily	Desmosomal cadherins	DSG1 DSG4	3.80e-04	7	78	2	1188
GeneFamily	Plexins	PLXNA3 PLXNC1	6.49e-04	9	78	2	683
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PRKD2 KIF1B AFAP1 PRKD1 ADAP2	1.97e-03	206	78	5	682
GeneFamily	DNA polymerases	REV3L POLK	4.38e-03	23	78	2	535
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PLXNA3 FNBP1 AFF2 MAP1B ACVR2A REV3L UBN2 NDST3 NALF1 SEMA6D NETO1 PLXNC1 GNAO1 GNAZ ATP1B1 EPB41L1 ZNF697 DOP1B	4.17e-06	1106	123	18	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	PLXNA3 MAP1B KALRN ACVR2A REV3L NALF1 SEMA6D PLXNC1 GNAO1 ATP1B1 EPB41L1 ZNF697	2.04e-05	584	123	12	M39068
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	PLXNA3 FNBP1 MAP1B NALF1 SEMA6D PLXNC1 COBL GNAO1 GNAZ EPB41L1 ZNF697	2.74e-05	506	123	11	M39067
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	WSCD1 CASP8AP2 MAP1A MAP1B DYNC2H1 RNF44 CHD2 ACTN2 ACVR2A REV3L ITGB8 AFAP1 PLXNC1 SETBP1 DMRTA1 GNAO1 ATP1B1 CCDC171 ALOX15	1.67e-06	989	116	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CASP8AP2 MAP1B VPS13C CHD2 ACVR2A ITGB8 PLXNC1 SETBP1 DMRTA1 GNAO1 CCDC171	1.88e-06	328	116	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	CASP8AP2 AFF2 MAP1A KALRN DLGAP5 REV3L RREB1 DDIAS RGL1 SEMA6D HOXD9 PLXNC1 PRKD1 BMPER ATP1B1	4.48e-05	827	116	15	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHA6 C10orf90 GDPD4 NDST3 SYT15 NETO1 PLXNC1	1.76e-07	148	122	7	dfd3f2c4b884ea9e23831a242a89ac985b409640
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	MAP1B RAET1E AFAP1 NALF1 COBL PRKD1 ALOX15	7.98e-07	185	122	7	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL MAP1A MAP1B DYNC2H1 CFAP52 VWA3B DNAH5	7.98e-07	185	122	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	MAP1B RAET1E AFAP1 NALF1 COBL PRKD1 ALOX15	9.20e-07	189	122	7	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KIF26A SMYD1 RAET1E CD93 SYT15 NALF1 GNAZ	1.13e-06	195	122	7	517af3e6784f02c382df6f5691945eefaa9ec4ae
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WSCD1 FNBP1 KIF1B TTYH3 SEMA6D CLMN GNAO1	1.17e-06	196	122	7	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5 ALOX15	1.21e-06	197	122	7	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5	1.21e-06	197	122	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5 ALOX15	1.21e-06	197	122	7	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5 ALOX15	1.21e-06	197	122	7	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5 ALOX15	1.21e-06	197	122	7	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF2 MAP1B KALRN ACTN2 CLMN SETBP1	8.28e-06	173	122	6	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A MAP1B CFAP52 VWA3B DNAH5 ALOX15	1.04e-05	180	122	6	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.04e-05	180	122	6	7a9aa96fb8035020640cc7d3df0c41c730516c6f
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF2 MAP1B SEMA6D CLMN BMPER ZNF697	1.07e-05	181	122	6	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A MAP1B DYNC2H1 CFAP52 VWA3B DNAH5	1.11e-05	182	122	6	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.21e-05	185	122	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL MAP1A DYNC2H1 CFAP52 VWA3B DNAH5	1.25e-05	186	122	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.29e-05	187	122	6	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	AFF2 MAP1B SEMA6D CLMN BMPER ADAP2	1.29e-05	187	122	6	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.33e-05	188	122	6	82c006f43c93f4a867953a446864f02b44536a23
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.33e-05	188	122	6	da59b5c0a4b11690a39a964c1a0a83e66aa0972b
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A MAP1B CFAP52 VWA3B DNAH5 ALOX15	1.33e-05	188	122	6	606907c865bd2f11bb6474932716550f7723d858
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN MAP3K20 GNAT1 ATP1B1 EPB41L1 ADAP2	1.41e-05	190	122	6	1d8e169d2448a34180c415843bb49aa45ed540c5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB8 NALF1 CLMN PRKD1 DNAH5 EPB41L1	1.45e-05	191	122	6	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB8 NALF1 CLMN PRKD1 DNAH5 EPB41L1	1.45e-05	191	122	6	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WSCD1 KIF26A CD93 SYT15 HOXB9 HOXD9	1.54e-05	193	122	6	3a5090f81f35026f435f4a250d1e77601a53af15
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL DYNC2H1 CLMN VWA3B DNAH5 ALOX15	1.54e-05	193	122	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WSCD1 KIF26A CD93 SYT15 HOXB9 HOXD9	1.54e-05	193	122	6	13731b7fc1e3bec0cebc44bad7e2ecea358bb76a
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WSCD1 KIF26A CD93 SYT15 HOXB9 HOXD9	1.54e-05	193	122	6	88cd7d0d0da5c776b49fc131f746fe5ad9676fb7
ToppCell	LAM-Epithelial-AirwayEpi\|Epithelial / Condition, Lineage and Cell class	MAP1A MAP1B CFAP52 CLMN VWA3B ALOX15	1.54e-05	193	122	6	f2672d2c495ee12c3b7d132452bde581fa5a7856
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB8 CLMN COBL PRKD1 DNAH5 EPB41L1	1.59e-05	194	122	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL MAP1A DYNC2H1 CFAP52 VWA3B DNAH5	1.59e-05	194	122	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B KIF1B UBR4 PRKD1 GNAI2 GNAO1	1.59e-05	194	122	6	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|Epithelial_cells / Location, Cell class and cell subclass	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.63e-05	195	122	6	a3e2999fdd4c3575add6e28ecfd1d6606a61f992
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A DYNC2H1 CFAP52 VWA3B DNAH5 ALOX15	1.63e-05	195	122	6	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5	1.63e-05	195	122	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5	1.63e-05	195	122	6	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	NALF1 SEMA6D CLMN PRKD1 DNAH5 EPB41L1	1.68e-05	196	122	6	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	(08)_PNEC\|World / shred by cell type and Timepoint	WSCD1 MAP1B NALF1 NETO1 GZMA GNAO1	1.68e-05	196	122	6	2ee37155c03cd5009427a4bffe6c80ed2ac6939e
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MAP1B SEMA6D CLMN BMPER ZNF697	1.73e-05	197	122	6	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CERKL MAP1A DYNC2H1 CFAP52 VWA3B DNAH5	1.73e-05	197	122	6	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C10orf90 PLA2G4C CLMN COBL GNAO1 ATP1B1	1.73e-05	197	122	6	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AFF2 MAP1B SEMA6D CLMN BMPER ZNF697	1.73e-05	197	122	6	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5	1.78e-05	198	122	6	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TTYH3 NDST3 CD93 RGL1 ATP1B1 ADAP2	1.78e-05	198	122	6	9aaff68107ae4542f904b142d23669f2fcd557ac
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B KALRN NALF1 NETO1 SETBP1 ATP1B1	1.78e-05	198	122	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TTYH3 NDST3 CD93 RGL1 ATP1B1 ADAP2	1.78e-05	198	122	6	5aaf3861c53763cf09bb628c9d2eabb6a7277021
ToppCell	Neuronal-Excitatory-eH(THEMIS)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.89e-05	200	122	6	651ee624ab62720546cf71c2191996b5be3ce846
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.89e-05	200	122	6	473e85930f433e392956a7a10ea5d09fdc2a35b1
ToppCell	(09)_Interm._secr.>cil.\|World / shred by cell type by condition	MAP1A DYNC2H1 CFAP52 CLMN VWA3B DNAH5	1.89e-05	200	122	6	3305e14dba12e94da42f0414fdc7a2c8caf0a183
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.89e-05	200	122	6	73b7e395398fdc9aa5adb3ade675ae0168d7f46c
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.89e-05	200	122	6	c9113e7a9624499db3e66c01462159e8e8781cc4
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1 ZNF697	1.89e-05	200	122	6	a737c4f535723e389ba4b957ae1fdc5162d3d951
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B ZNF689 F7 EPB41L1 ADAP2	4.35e-05	141	122	5	dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell	COVID-19-Mast_cells-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	ZNF132 AFF2 C10orf90 DMRTA1 CCDC171	4.97e-05	145	122	5	5c5fed4620c4c312d1052b8acad910453f7e8fcc
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CERKL ZNF132 RYR3 LIG3 SEMA6D	6.61e-05	154	122	5	16fdafb5c64d2db321554f87129a962d113f1668
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	MAP1B RAET1E NALF1 SEMA6D ALOX15	7.03e-05	156	122	5	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	PBMC-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	CERKL RGL1 PLXNC1 GZMA	7.29e-05	81	122	4	6d1e524f000b71c935359afc801a1d31f218fec8
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 TTYH3 RGL1 SEMA6D ADAP2	7.92e-05	160	122	5	a494001b1f6dec33624f98fa3c24bad6988d0425
ToppCell	facs-Marrow-KLS-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN2 RYR3 SETBP1 HFM1 BMPER	8.90e-05	164	122	5	d2b5f51af7fcffddebe997ee302bacbd85d76852
ToppCell	Ciliated_cells-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CERKL RYR3 CFAP52 VWA3B ALOX15	8.90e-05	164	122	5	0e9961acbb1d6c0089e6805ba6756736fa4d8bed
ToppCell	10x5'-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	MAP1A ACTN2 ANKRD53 PRKD1 HMHB1	9.96e-05	168	122	5	90f713dae3fcbd6ca801a019e3861c263ff3366b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	PRKD2 ZBTB2 NETO1 PRKD1 HPS5	1.02e-04	169	122	5	29db25e7c5f31d98a08a35d7ec5ade203242bc50
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	PRKD2 ZBTB2 NETO1 PRKD1 HPS5	1.02e-04	169	122	5	b1611e61f635f8f9b87250e026ad30999cbee041
ToppCell	Endothelial-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MAP1B KALRN ANKRD53 NDST3 HOXD9	1.02e-04	169	122	5	8889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD93 RGL1 PLXNC1 IRAK3 ADAP2	1.05e-04	170	122	5	9ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	AFF2 MAP1B SEMA6D BMPER ZNF697	1.08e-04	171	122	5	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	WSCD1 PRKD2 DCST1 CD93 NALF1	1.08e-04	171	122	5	3112d15f2a28cf4a71992db4971d960716dc1264
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B ZNF697	1.24e-04	176	122	5	03d194c9814e12802cd932afade69e868814cb78
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 SMYD1 ITGB8 SEMA6D ZNF804B	1.24e-04	176	122	5	de746cdf2c777eec88cb03863e128e97ad6e8fb0
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 SMYD1 ITGB8 ZNF804B ZNF697	1.27e-04	177	122	5	64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	KIF26A CD93 HOXB9 HOXD9 GNAZ	1.27e-04	177	122	5	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 NALF1 HOXD9 CLMN ATP1B1	1.27e-04	177	122	5	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B ZNF697	1.31e-04	178	122	5	a62137d7f5fac16619f8a02844cdb0be7a794bf2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B ZNF697	1.34e-04	179	122	5	820289f14ecf165758529c236bb220bb1a744f02
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B ZNF697	1.34e-04	179	122	5	e5f781d35449628a7f356d71e26231dd63482eec
ToppCell	facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 KALRN HOXD9 ATP1B1 EPB41L1	1.38e-04	180	122	5	fc5b9d0e3215652e490ca72d69f776e9725608b2
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CERKL MAP1A DYNC2H1 VWA3B DNAH5	1.38e-04	180	122	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 KALRN HOXD9 ATP1B1 EPB41L1	1.38e-04	180	122	5	6763b22f2383931c747b37cd0ae2f60b08f64d90
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	AFF2 HMGB4 ZNF804B PRKD1 GNAO1	1.41e-04	181	122	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1	1.41e-04	181	122	5	13270b6ba6a9c8e5681c6f40000c643ce1d9344a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMYD1 ITGB8 SEMA6D ZNF804B GNAO1	1.41e-04	181	122	5	3e3c903b522dced6bec5dc447cc3f8bf9a9749e3
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF2 SMYD1 ITGB8 SEMA6D ZNF804B	1.41e-04	181	122	5	b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CASP8AP2 TTYH3 CD93 PLXNC1 GNAI2	1.45e-04	182	122	5	4a85429d365c4b2d73fc921f261b4b7635ac40bd
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CASP8AP2 TTYH3 CD93 PLXNC1 GNAI2	1.45e-04	182	122	5	53213af34af3337f5edc734d3b7b79e4349eac0d
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CASP8AP2 TTYH3 CD93 PLXNC1 GNAI2	1.45e-04	182	122	5	7909089ed6325c44edd6f9b7e8b1d542398222ea
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 SEMA6D HOXD9 CLMN ATP1B1	1.49e-04	183	122	5	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF1B MAP3K20 TTYH3 CD93 GNAI2	1.53e-04	184	122	5	d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCell	Mild_COVID-19-Myeloid-MoAM4\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TTYH3 RGL1 PLA2G4C PLXNC1 DOP1B	1.53e-04	184	122	5	63ef6ba6ac33c3032735008ce3b411636ab3c395
ToppCell	Ciliated_cells-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CFAP52 VWA3B DNAH5 ALOX15	1.53e-04	184	122	5	07c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPA1 MAP3K20 GDPD4 SYT15 ADAP2	1.53e-04	184	122	5	f4344f3c407b2d4d703fe56e43d84dbfe60ba833
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHA6 KIF26A CD93 SYT15 BMPER	1.56e-04	185	122	5	f98af3146ec2f44c30d31a662fb9c4fa3ca4f706
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	AFF2 MAP1B SEMA6D CLMN BMPER	1.56e-04	185	122	5	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_1\|390C / Donor, Lineage, Cell class and subclass (all cells)	FASTKD5 UBASH3A AFAP1 GLIPR1L2 EPB41L1	1.60e-04	186	122	5	064b6047215597465bb51a8a1547ef5a226552f9
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WSCD1 MAP1B KIF26A CD93 SYT15	1.60e-04	186	122	5	b80aaeebc03a318052076d2f02c123f5ddc5e73a
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WSCD1 MAP1B KIF26A CD93 SYT15	1.60e-04	186	122	5	8a8ed1502542d4895cba3fd5d534256206578716
ToppCell	367C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FNBP1 GNAO1 GNAZ HPS5 ALOX15	1.64e-04	187	122	5	3748203b62abf51b74dfcfc4f18b3ba831b63a96
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	NALF1 CLMN PRKD1 DNAH5 EPB41L1	1.64e-04	187	122	5	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DYNC2H1 NALF1 SEMA6D COBL EPB41L1	1.64e-04	187	122	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
Computational	Neighborhood of MAP1B	RALGAPA1 CAND1 USP22 MAP1B KIF1B	6.18e-05	65	70	5	GCM_MAP1B
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAI2 GNAO1 GNAT1 GNAZ	1.74e-08	8	119	4	DOID:1858 (implicated_via_orthology)
Disease	photoreceptor cell layer thickness measurement	RALGAPA1 CERKL MAP1B ACTN3 RREB1 GDPD4 COBL	2.43e-06	148	119	7	EFO_0803370
Disease	IGF-1 measurement	EPHA6 MAP1A VPS13C RREB1 HFM1 DMRTA1 CDC5L HMHB1 HPS5 DOP1B	2.98e-05	488	119	10	EFO_0004627
Disease	uric acid measurement	PRKD2 DNAJC13 DYNC2H1 HECTD4 CHD2 ACVR2A RREB1 SETBP1 HFM1 GNAO1 ZNF697	3.78e-05	610	119	11	EFO_0004761
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	9.63e-05	4	119	2	cv:C0265275
Disease	sclerosing cholangitis	PRKD2 UBASH3A CREBBP GNAO1	1.49e-04	66	119	4	EFO_0004268
Disease	focal segmental glomerulosclerosis 1 (implicated_via_orthology)	ACTN2 ACTN3	1.60e-04	5	119	2	DOID:0111128 (implicated_via_orthology)
Disease	cognitive function measurement	KALRN MAP3K20 CHD2 RYR3 RGL1 EXD3 NALF1 SEMA6D EXD2 SETBP1 TTC21B VWA3B PRKD1 GNAI2 GNAO1 DNAH5	2.12e-04	1434	119	16	EFO_0008354
Disease	Epileptic encephalopathy	CHD2 RYR3 GNAO1	2.40e-04	30	119	3	C0543888
Disease	type 1 diabetes mellitus	PRKD2 UBASH3A ITGB8 COBL DMRTA1 GNAO1	4.59e-04	242	119	6	MONDO_0005147
Disease	Colorectal Carcinoma	MAP1B KALRN NDST3 CD93 LIG3 HOXD9 MCM3AP SETBP1 DMRTA1 PRKD1	5.66e-04	702	119	10	C0009402
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	8.66e-04	11	119	2	C0265275
Disease	pneumonia	ACVR2A EXD3 GNAO1	9.11e-04	47	119	3	EFO_0003106
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 TTC21B	1.22e-03	13	119	2	C0036996
Disease	Genetic chronic primary adrenal insufficiency	UBASH3A GNAO1	1.22e-03	13	119	2	Orphanet_101960
Disease	asthma, body mass index	ACTN3 ITGB8	1.42e-03	14	119	2	EFO_0004340, MONDO_0004979
Disease	C-C motif chemokine 19 measurement	DNAJC13 GNAO1	1.42e-03	14	119	2	EFO_0008047
Disease	Saldino-Noonan Syndrome	DYNC2H1 TTC21B	1.42e-03	14	119	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 TTC21B	1.42e-03	14	119	2	C0024507
Disease	household income	KALRN MAP3K20 FASTKD5 SEMA6D PRKD1 GNAI2	1.49e-03	304	119	6	EFO_0009695
Disease	response to platinum based chemotherapy, magnesium measurement	NTMT2 PRKD1	1.64e-03	15	119	2	EFO_0004647, EFO_0004845
Disease	waist circumference	RALGAPA1 BCKDK HECTD4 SETBP1 PRKD1 ATP1B1 DNAH5	1.81e-03	429	119	7	EFO_0004342
Disease	smoking behaviour measurement	MAP3K20 REV3L SEMA6D PLA2G12B GNAI2	2.10e-03	222	119	5	EFO_0005671
Disease	cannabis dependence	REV3L SEMA6D GNAI2 GNAT1	2.22e-03	135	119	4	EFO_0007191
Disease	lymphocyte count	CERKL KALRN ZNF689 KIF1B HECTD4 RREB1 UBASH3A MCM3AP HFM1 DMRTA1 GNAI2 GNAO1 CDC5L KIR2DS4	2.34e-03	1464	119	14	EFO_0004587
Disease	serum copper measurement	EPHA6 VWA3B	3.22e-03	21	119	2	EFO_0005267
Disease	autism spectrum disorder (implicated_via_orthology)	BCKDK CHD2 CREBBP NDST3	3.40e-03	152	119	4	DOID:0060041 (implicated_via_orthology)
Disease	fibrinogen measurement, coronary artery disease	DYNC2H1 HECTD4 GNAO1 ATP1B1	3.56e-03	154	119	4	EFO_0001645, EFO_0004623
Disease	neuroticism measurement	AFF2 ACVR2A NDST3 SEMA6D PLXNC1 EXD2 PRKD1 GNAI2 GNAO1 HMHB1	3.80e-03	909	119	10	EFO_0007660
Disease	gestational diabetes	DMRTA1 GNAO1	3.86e-03	23	119	2	EFO_0004593
Disease	parental longevity	HECTD4 MAP3K20 RYR3 SEMA6D SETBP1 GNAO1 CCDC171	3.96e-03	494	119	7	EFO_0007796

Protein segments in the cluster

Peptide	Gene	Start	Entry
DALRHFNKARKDRDW	TTC21B	1041	Q7Z4L5
HERGERKVCRFKLEW	ATP1B1	141	P05026
SLLHRKSAKQCKARW	CDC5L	36	Q99459
RKTFTAWCNSHLRKA	ACTN2	41	P35609
WCRVKDNKLIFHKDR	AFAP1	366	Q8N556
CHYEQDRSALKKREW	AFF2	16	P51816
FKCTENARFLKTWRD	C4orf46	86	Q504U0
KRRHCFATWKNISGS	ACVR2A	56	P27037
TSQQKWKEECRRFEH	CCDC171	136	Q6TFL3
KDWVLTAAHCNLNKR	GZMA	61	P12544
ALCSAHLKFRTTRKW	GPR32	171	O75388
HLKFRTTRKWNGCTH	GPR32	176	O75388
SNWHKELRNSCISKR	CD93	126	Q9NPY3
ARDKHWEFSSLRRSK	CREBBP	1671	Q92793
IEKWVDFARRLCEHK	BCKDK	231	O14874
RRGWEDCKRDKSVNS	CASP8AP2	411	Q9UKL3
EPFKKRWFALDCHER	ADAP2	271	Q9NPF8
NHTFCLKCIRKWRSA	MKRN4P	341	Q13434
RHRDIWSKEKTCDRL	NDST3	581	O95803
FRKLSKGDCDHWLRE	RAET1E	181	Q8TD07
WDENHCKEKRKTSLL	NETO1	321	Q8TDF5
VDRRHWVSECKAKQS	NTF4	161	P34130
KWINIAHECRLLKNF	RGL1	311	Q9NZL6
WTTCRANKQKRHLLE	RIC1	721	Q4ADV7
CKIWNHRACARFLKD	ANKRD53	251	Q8N9V6
NHRSAKRLWKVCIEH	EPB41L1	356	Q9H4G0
LFFLLHRWCSDKKNA	KIR2DS4	261	P43632
DTLRKRHYWRLDSKC	PRKD1	436	Q15139
SDRKSCFWKLVRHLD	MAP1A	66	P78559
KSCFWKLIRHLDRVD	MAP1B	291	P46821
RTARAWGKKCLFTHN	GLIPR1L2	86	Q4G1C9
RSERKKWIHCFEGVT	GNAT1	201	P11488
FRKWKSHQFTSLRDL	KIF1B	751	O60333
SADDLHRWFNRKKTS	DOP1B	1021	Q9Y3R5
HRWFNRKKTSFREAC	DOP1B	1026	Q9Y3R5
ENLLHRTYCRWKSKS	MCM3AP	1711	O60318
RSFLCDTEREKFWKI	HPS5	196	Q9UPZ3
RQKREWIKFAAACRE	DSG4	46	Q86SJ6
SWKVRRAAAKCLDAV	CAND1	346	Q86VP6
CAKKDIRVWHTSSNR	CFAP52	351	Q8N1V2
NDDHSSWRKVLEKCQ	EXD2	271	Q9NVH0
KIECDWKRLNSLAHY	PLXNA3	1551	P51805
KRVSWDFKTAESHCK	PLXNC1	341	O60486
RWSKNQDDSFTICRK	DDIAS	616	Q8IXT1
LHFWTLKKRRLDQCQ	KALRN	1116	O60229
DTLRKRHYWRLDCKC	PRKD2	411	Q9BZL6
RKRHLLKDDAWFCNW	ALOX15	66	P16050
AANWIHARSTRKKRC	HOXD9	276	P28356
RHCHTKLVELKRQAW	KIF26A	71	Q9ULI4
LFFLLHRWCSDKKNA	KIR2DS3	261	Q14952
IFCFHWRRETEKEKL	GDPD4	486	Q6W3E5
QWLLTAAHCRKKVFR	KLK5	101	Q9Y337
QCKKHWKRFLSELEV	IRAK3	201	Q9Y616
AKFRWCLHSICSDLK	PLA2G12B	131	Q9BX93
RCTRIRDDKDWKSAT	LIG3	806	P49916
CIDVRHAQKASRKWT	HECTD4	3446	Q9Y4D8
ECREEKRGSLHVWKS	HMHB1	6	O97980
RQKREWIKFAAACRE	DSG1	46	Q02413
WFSQRCRKINHSKSS	NUP155	246	O75694
SANWLHARSSRKKRC	HOXB9	176	P17482
AKCFRCKLWENSLHV	HFM1	916	A2PYH4
CESHIGWRKEAKRLL	ITGB8	266	P26012
KHRFTRQEWDLAKSL	PLA2G4C	106	Q9UP65
ATENRKLRKWHTTFC	DYNC2H1	686	Q8NCM8
RVAHCRSKDVAKILW	FASTKD5	421	Q7L8L6
RSERKKWIHCFEGVT	GNAZ	206	P19086
AHRECQKLKSWEFQT	BMPER	556	Q8N8U9
HIETCWKQLESSKRR	FNBP1	126	Q96RU3
WKQLESSKRRFERDC	FNBP1	131	Q96RU3
CLKAYSDQEHIKLWR	CHD2	1516	O14647
ILSCRRWFDRKHEQC	DCST1	256	Q5T197
ALCSAHLKFRTTRKW	GPR32P1	171	Q8NGA4
VSALKGHKRFCRWRD	DMRTA1	106	Q5VZB9
KVREFWRCNSVEKHL	COBL	766	O75128
TEKLTSHCFEWDRKL	DLGAP5	441	Q15398
DHCDIWFRQFKKILA	CERKL	146	Q49MI3
CRSSVWSAFKDQKHD	DNAJC13	2181	O75165
DKCNSFLHNKAEWRC	MAP3K20	271	Q9NYL2
FKVRGLLDCKHSWKR	ALOX12B	221	O75342
LRTLAQAKKECWDRF	CCDC32	101	Q9BV29
CTWKFARSDELNRHK	KLF18	1001	A0A0U1RQI7
LWKHECKRVIADRFT	DNAH5	2821	Q8TE73
HCWQKERNHRPKFTD	EPHA6	911	Q9UF33
CKKWALHIVARLFER	IPO8	261	O15397
LFFLLHRWCSDKKNA	KIR2DS1	261	Q14954
RSRWQKTDDELCRHS	NTMT2	11	Q5VVY1
KELVKRWHALCRTTE	SYT15	406	Q9BQS2
LESFLHDSWRQKRDK	RPL7L1	61	Q6DKI1
AAHCFDKIKNWRNLI	F7	251	P08709
FSRKCSEKWRSISKH	HMGB4	41	Q8WW32
RSERKKWIHCFEGVT	GNAI2	206	P04899
RSERKKWIHCFEDVT	GNAO1	206	P09471
DAWLNHKNECSAIKR	SMYD1	81	Q8NB12
WDGEQKTHCFKERTR	SIX6	126	O95475
EKFRQKASLHEAWTR	ACTN3	411	Q08043
RTFTRWINLHLEKCN	CLMN	36	Q96JQ2
VHKLCNESRKLWRAL	CLBA1	186	Q96F83
LCERRKYWVTHADDK	C10orf90	216	Q96M02
KFFSRKSSLICHWRV	ZNF132	606	P52740
TSFIRQHKDQWFKCD	USP22	481	Q9UPT9
KKFHWDDTIRTLLCN	UBN2	601	Q6ZU65
RSKRWDECLKIFSHN	TRPA1	601	O75762
KLKEASRAHWQGCRK	ZNF804B	601	A4D1E1
CDKTFVASWDLKRHA	ZNF668	341	Q96K58
SWDKRRSFHLLKKNE	RALGAPA1	1776	Q6GYQ0
QRWDSNIEEHCAKKR	REV3L	471	O60673
VCNKRFWSLQDLTRH	RREB1	1516	Q92766
AEVFILWCKSHNFKR	RYR3	3296	Q15413
SWDKRKSSFHNVDRL	SPATA31D1	1126	Q6ZQQ2
EFHTKCVDKWLKANR	RNF44	401	Q7L0R7
SLCKEWEAAVRRKNF	THAP1	31	Q9NVV9
SFFDKKRSERKWSHQ	POLK	566	Q9UBT6
KRSERKWSHQDTFKC	POLK	571	Q9UBT6
ARAEETWKKCRFQHP	VPS13C	761	Q709C8
CNKCDKAFIKRSHLW	ZNF677	461	Q86XU0
CGKRFSWRSDLVKHQ	ZNF697	386	Q5TEC3
FRQRWSLAVHKCSPK	ZNF689	466	Q96CS4
CNECEKSFWRKDHLI	ZNF510	546	Q9Y2H8
TICGRKFIQKSHWRE	ZBTB2	366	Q8N680
KCKWYSERIHTALAR	VWA3B	471	Q502W6
EKDHWRSRRTICVKT	WSCD1	396	Q658N2
EKHWTSFLKARLNCS	SEMA6D	271	Q8NFY4
LHNAAVDWLSRCKKY	UBR4	1556	Q5T4S7
IQHPKFAAKRRWTCS	SETBP1	521	Q9Y6X0
FWLCCRRRKSEEHLD	TTYH3	66	Q9C0H2
FWRESKRQCAKNRAH	UBASH3A	91	P57075
LWFCAEAKLTRARDK	NALF1	56	B1AL88
CHKRFVEKSLSQENW	EXD3	271	Q8N9H8